-
Camber Pharmaceuticals Launches Generic Toviaz®
17 Apr 2024 16:38 GMT
Piscataway, NJ, April 17, 2024–Camber Pharmaceuticals is excited to introduce Fesoterodine Fumarate Extended-Release Tablets.
According to the Cleveland Clinic, approximately 33 million Americans struggle with overactive bladders, impacting about 30% of …
-
Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, Date of authorisation: 20/04/2007, Revision: 28, Status: Authorised
08 Dec 2023 14:47 GMT
… reported with Toviaz, see the package leaflet.
Toviaz must not … eye pressure even with treatment);
myasthenia gravis (a disease … complication of colitis).
Toviaz must not be given … strong CYP3A4 inhibitor medicines. These include medicines such as ketoconazole …
-
Analyzing Access and Costs of Oral Medications for Overactive Bladder (OAB): Uncovering Disparities.
08 Oct 2023 08:32 GMT
… with Overactive Bladder (OAB) medications among Medicare beneficiaries and the uninsured. … Medicare & Medicaid Services Prescription Drug Plan Formulary Data (Q1-2022). FDA-approved medications … -name ACHs ranged from $1175 (Toviaz ER) to $2198 (Oxytrol). …
-
Medicines for high heat: From dry mouth to dizziness
26 Mar 2023 04:01 GMT
… drugs for urinary incontinence and certain antidepressants. … parched. These medications include:
means … Puren), fesoterodine (in Toviaz), desfesoterodine (in Tovedeso … doctor called immediately (telephone 112). The patient needs intensive care treatment …
-
Lupin receives approval from U.S. FDA for Fesoterodine Fumarate Extended-Release Tablets
07 Jan 2023 00:22 GMT
… United States Food and Drug Administration (FDA) for its Abbreviated New … Drug Application (ANDA), Fesoterodine … Toviaz® Extended-Release Tablets, 4 mg and 8 mg, of Pfizer … and 8 mg, (RLD Toviaz®) had estimated annual sales of …
-
USFDA gives final nod to Alembic Pharmaceuticals’ tablets for overactive bladder
06 Jan 2023 14:49 GMT
Alembic Pharmaceuticals Limited on Friday announced … to the reference listed drug product (RLD), Toviaz Extended-Release Tablets, … 4 mg and 8 mg, of Pfizer … Tablets are indicated for the treatment of overactive bladder (OAB) …
-
Alembic Pharma gets USFDA nod for generic medication
06 Jan 2023 06:49 GMT
Alembic Pharmaceuticals on Friday said … USFDA) for its abbreviated new drug application (ANDA) for Fesoterodine … therapeutically equivalent to Pfizer Inc's Toviaz extended-release tablets … tablets are indicated for the treatment of overactive bladder (OAB) …
-
Alembic Pharmaceuticals receives USFDA Final Approval for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg
06 Jan 2023 06:18 GMT
… to the reference listed drug product (RLD), Toviaz Extended-Release Tablets, 4 … Pfizer Inc. (Pfizer). Fesoterodine Fumarate Extended-Release Tablets are indicated for the treatment … ) from USFDA.
Shares of Alembic Pharmaceuticals Limited was last trading in …
-
Dr Reddy’s share price rises 4% on new drug launch in US; what should investors do with this pharma stock?
11 Jul 2022 09:11 GMT
… , a therapeutic generic equivalent to Toviaz (fesoterodine fumarate) extended-release tablets … the U.S. Food and Drug Administration (USFDA). The company said …
-
Dr Reddy's gains over 3% on new drug launch in the US market
11 Jul 2022 07:08 GMT
… , a therapeutic generic equivalent to Toviaz® (fesoterodine fumarate) extended-release tablets … the U.S. Food and Drug Administration (USFDA). The company’s … 30.
According to IQVIA, the Toviaz brand had sales of approximately …